Disposable Endoscopes Market: Infection Control Imperatives, ERCP Single-Use Adoption, and Regulatory Mandates to Drive Exceptional 23.2% CAGR Market Growth Through 2035

The global Disposable Endoscopes market was valued at USD 1.1 billion in 2025 and is projected to reach USD 7.19 billion by 2035, advancing at an exceptional CAGR of 23.2% — one of the highest growth rates within the entire medical devices sector. The market encompasses disposable single-use endoscopes across urology endoscopes, bronchoscopes, cystoscopes, gastrointestinal endoscopes, laryngoscopes, arthroscopes, and other categories, segmented by clinical usage (surgical versus diagnostic) and by application across urology, bronchoscopy, gastroenterology, ENT, orthopedics, and pulmonology. End users include hospitals, ambulatory surgery centres, clinics, and specialty endoscopy centres.

The disposable endoscopes market is at an early stage of a structural adoption curve that is being driven by a fundamental shift in the medical community’s perception of flexible endoscope reprocessing reliability. Multiple documented outbreaks of carbapenem-resistant organism transmission through inadequately reprocessed duodenoscopes, followed by FDA mandates requiring manufacturers to redesign duodenoscopes for easier reprocessing or transition to disposable designs, have catalysed hospital endoscopy department evaluation of single-use alternatives across all flexible endoscope categories beyond duodenoscopes. With the market currently below USD 2 billion and the addressable flexible endoscope procedure market exceeding USD 50 billion, the penetration opportunity sustaining 23.2% CAGR growth is substantial and the adoption trajectory is in an early-stage inflection.

Executive Snapshot

What FDA regulatory actions are accelerating disposable endoscope adoption in gastroenterology?
The U.S. FDA issued a safety communication and subsequently a mandatory recall and redesign order for reusable duodenoscopes following documented multidrug-resistant organism outbreaks at multiple U.S. academic medical centres attributable to reprocessing failures in the duodenoscope elevator mechanism — a complex channel that is difficult to access for cleaning and high-level disinfection. FDA recommended that manufacturers transition duodenoscopes to either disposable designs, disposable elevator components, or enhanced reprocessing designs validated for more reliable reprocessing. Endoscopy programmes evaluating regulatory-compliant duodenoscope alternatives are accelerating disposable duodenoscope adoption at ERCP programmes as the path of least regulatory and infection control risk.

How do total cost of ownership analyses compare reusable versus disposable endoscope programme economics?
Published total cost of ownership analyses comparing reusable endoscope programme costs to single-use disposable alternatives must account for the full cost components of reusable programmes: acquisition cost, automated reprocessor machine capital, reprocessing chemical consumables, reprocessing technician labour, bronchoscope repair and maintenance contracts, scope tracking system investment, regulatory compliance documentation per reprocessing cycle, and cost of reprocessing-related infection events. At sufficient procedure volumes per year, the per-procedure total cost of single-use endoscopes is within 10 to 20 percent of reusable programme costs when all reprocessing overheads are fully attributed, with many published models demonstrating cost parity or single-use advantage at typical ICU bronchoscopy and ERCP programme volumes.

What clinical quality advantages do high-definition single-use endoscopes provide versus older reusable systems?
Contemporary single-use endoscopes — particularly bronchoscopes and ureteroscopes — are manufactured with new optical components at each use, eliminating the image quality degradation from lens contamination, fibre bundle breakage, and scope body wear that accumulates over the reprocessing and repair cycle lifetime of reusable flexible endoscopes. Single-use bronchoscopes available from Ambu and Olympus deliver high-definition video imaging equal to or exceeding reusable bronchoscopes that have undergone multiple reprocessing and repair cycles, and single-use digital ureteroscopes deliver endoscopic image resolution superior to many ageing fibre-optic reusable ureteroscopes that remain in clinical service at institutions with constrained capital replacement budgets.

How is single-use ureteroscope adoption reshaping the urology endoscopy market?
Disposable digital ureteroscopes for flexible ureteroscopy in kidney stone management and upper tract urothelial carcinoma diagnosis have achieved particularly rapid adoption at urology departments where the high per-use repair cost and fragility of reusable fibre-optic ureteroscopes create high reprocessing and repair cost per procedure. Studies of reusable ureteroscope lifecycle costs report per-procedure repair costs of USD 100 to 400 per scope use when repair and maintenance contracts are amortised, and single-use digital ureteroscopes priced in the USD 200 to 450 per unit range provide a cost-competitive alternative with the additional benefit of always-new optical quality and no repair scheduling delays.

What is driving single-use laryngoscope adoption in emergency airway management and anaesthesia?
Single-use videolaryngoscope blades and handles for emergency airway management and elective anaesthesia intubation are growing from infection control imperatives in emergency and anaesthesia settings where rapid-sequence reprocessing between cases is difficult to reliably execute, and from clinical preference for guaranteed sterile blade surface at each use for immunocompromised, infectious, and high-risk patients. The COVID-19 pandemic accelerated single-use videolaryngoscope adoption at emergency departments and operating rooms as aerosol-generating procedure infection risk heightened infection control focus on airway management equipment sterility.

Which disposable endoscope segments are growing fastest?
Single-use duodenoscopes driven by FDA regulatory mandate, single-use digital ureteroscopes from reusable repair cost parity and optical quality advantage, single-use bronchoscopes from ICU cross-contamination risk reduction, and single-use cystoscopes from outpatient and office-based urology procedure growth are the four fastest-growing disposable endoscope segments.

Market Dynamics: Disposable Endoscopes Market

  • FDA regulatory mandate and MDRO outbreak evidence accelerating duodenoscope disposable adoption at ERCP programmes as the lowest infection control risk compliance pathway.
    FDA duodenoscope redesign mandate sustaining single-use ERCP endoscope adoption at U.S. hospital ERCP programmes as the regulatory-compliant lowest-risk reprocessing pathway.
  • Total cost of ownership parity at typical procedure volumes sustaining economic rationale for single-use conversion above infection control motivation alone.
    Cost parity evidence at typical programme volumes sustaining single-use endoscope economic rationale at hospital departments evaluating reusable programme conversion to disposable alternatives.
  • Single-use digital ureteroscope adoption from repair cost parity and always-new optical quality versus ageing reusable fibre-optic ureteroscope fleets.
    Single-use digital ureteroscope adoption sustaining urology endoscopy market revenue growth from repair cost parity and optical quality advantage above ageing reusable fibre-optic ureteroscope programmes.
  • Early adoption inflection on a 23.2% CAGR trajectory from a sub-USD 2 billion base with a >USD 50 billion addressable procedure market representing substantial remaining penetration opportunity.
    Disposable endoscope market early adoption inflection sustaining exceptional 23.2% CAGR from the large untapped addressable flexible endoscope procedure market remaining to be converted to single-use.
  • Single-use laryngoscope pandemic-accelerated adoption sustained in emergency and anaesthesia settings from infection control preference for guaranteed sterile blade at each use.
    Single-use videolaryngoscope adoption sustained in emergency and anaesthesia from COVID-19-accelerated infection control preference for single-use airway management instrument sterility.
  • ICU infection control imperatives sustaining single-use bronchoscope adoption at immunocompromised patient programmes beyond initial haemato-oncology and transplant ICU early adopters.
    Single-use bronchoscope adoption expanding beyond haemato-oncology and transplant ICU early adopters to general medical and surgical ICU programmes from sustained infection control rationale.

Market Segmentation: Disposable Endoscopes Market

By Type
  • Urology Endoscopes
  • Bronchoscopes
  • Cystoscopes
  • Gastrointestinal (GI) Endoscopes
  • Laryngoscopes
  • Arthroscopes
  • Other Disposable Endoscopes
By Clinical Usage
  • Surgical Usage
  • Diagnostic Usage
By Application
  • Urology
  • Bronchoscopy
  • Gastroenterology
  • ENT (Ear, Nose & Throat)
  • Orthopedics
  • Pulmonology
  • Other Applications
By End User
  • Hospitals
  • Ambulatory Surgery Centers (ASCs)
  • Clinics
  • Specialty Endoscopy Centers
  • Other End Users
By Geography
  • North America: United States, Canada, and Mexico
  • Europe:  Germany, U.K., France, Italy, Spain, Russia, Benelux, Nordics, and Rest of Europe
  • Asia Pacific: China, Japan, India, South Korea, Australia, New Zealand, Taiwan, South East Asia, and Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Columbia, Chile, Peru, and Rest of Latin America
  • Middle East: Saudi Arabia, United Arab Emirates, Oman, Qatar, and Rest of Middle East
  • Africa: Nigeria, Egypt, Ethiopia, South Africa, and Rest of Africa

Key Growth Drivers: Disposable Endoscopes Market

  1. FDA duodenoscope redesign mandate sustaining single-use ERCP endoscope adoption as the regulatory-compliant lowest infection control risk compliance pathway.
    FDA regulatory mandate driving disposable duodenoscope adoption at U.S. ERCP programmes as compliance with endoscope infection control standards.
  2. Cost parity at typical programme volumes sustaining economic rationale for single-use conversion above infection control motivation alone.
    Single-use endoscope cost parity evidence sustaining conversion rationale at hospital programmes fully attributing reprocessing overhead costs in per-procedure total cost accounting.
  3. Single-use digital ureteroscope repair cost parity and always-new optical quality sustaining urology endoscopy disposable adoption.
    Disposable digital ureteroscope adoption growing from reusable repair cost parity and optical quality advantage above ageing fibre-optic reusable ureteroscope fleets.
  4. 23.2% CAGR early adoption inflection on a sub-USD 2 billion base with large remaining flexible endoscope procedure market penetration opportunity.
    Exceptional CAGR reflecting early inflection in disposable endoscope adoption curve against large addressable flexible endoscope procedure market.
  5. Single-use laryngoscope pandemic-accelerated adoption sustained in emergency and anaesthesia infection control.
    Single-use laryngoscope adoption sustained in emergency and anaesthesia from COVID-19-accelerated infection control focus on airway management sterility.
  6. ICU bronchoscope adoption expanding from haemato-oncology ICU early adopters to general medical and surgical ICU programmes.
    Single-use bronchoscope adoption expanding beyond early adopter haemato-oncology ICU programmes to general ICU settings from sustained infection control rationale.

Regional Outlook: Disposable Endoscopes Market

  • North America: The largest and fastest-growing disposable endoscopes market, driven by FDA regulatory mandate for duodenoscope redesign or transition to disposable, strong ICU single-use bronchoscope adoption following MDRO outbreak regulatory scrutiny, and rapid single-use digital ureteroscope penetration at urology programmes evaluating reusable scope repair cost parity.
  • Europe: Germany, France, the UK, and the Benelux countries anchor European disposable endoscopes demand, with EU MDR compliance requirements and CE marking pathways accelerating single-use endoscope validation and commercial launch. European hospital infection prevention committees are actively evaluating single-use duodenoscope programmes following European MDRO outbreak documentation from reusable duodenoscope reprocessing failures.
  • Asia-Pacific: The fastest-growing regional disposable endoscope market, driven by Japan’s large procedure volumes and Olympus single-use bronchoscope commercial availability, China’s growing endoscopy infrastructure and domestic single-use endoscope manufacturer competition, and India’s rapidly expanding private hospital endoscopy programme investment in single-use instruments for infection control capability.

Competitive Landscape: Disposable Endoscopes Market

Key Players: Ambu A/S, Olympus Corporation (Vaya Disposable), Boston Endoscopy, Innovizio Medical, Aohua Endoscopy, Endoseer, Vedkang Medical, SoloEndoscopy, Urotronic (Ureteroscopes), Print Medical, Purevision, Blue Kite Medical, NephROS, Vision Sciences, Laborie Medical Technologies, Pentax Medical, Koelis (Urology Navigation), Stryker (Arthroscopy Single-Use)

  • Ambu A/S confirmed that its aScope Duodeno single-use duodenoscope has been adopted at U.S. ERCP programmes as a primary response to FDA regulatory guidance on duodenoscope reprocessing compliance, with Ambu reporting that aScope Duodeno procedure volumes are accelerating as hospital endoscopy programmes convert from reusable duodenoscope programmes to single-use ERCP instruments, and noting that the aScope Duodeno’s digital high-definition imaging and integrated working channel deliver ERCP procedural capability equivalent to reusable duodenoscope platforms at adopting gastrointestinal endoscopy centres.
  • Olympus Corporation launched its Vaya disposable bronchoscope commercially across U.S. and European markets targeting hospital ICU and bronchoscopy suite accounts seeking a large working channel single-use bronchoscope for therapeutic bronchoscopy and complex diagnostic procedures including BAL sampling in immunocompromised ICU patients, with Olympus noting that Vaya’s 2.8 mm working channel diameter enables passage of therapeutic accessory devices including forceps and cytology brushes that narrower working channel competitive single-use bronchoscopes cannot accommodate.
  • Vedkang Medical reported growing international commercial traction for its single-use flexible ureteroscope products at European and Asia-Pacific urology endoscopy programmes, with Vedkang noting that its disposable digital ureteroscope product line is being evaluated at European university hospital urology departments as a cost-effective alternative to reusable fibre-optic ureteroscope programmes where high per-procedure repair costs and scope availability constraints create workflow disruptions at high-volume stone treatment programmes.

Consultant POV

The Disposable Endoscopes market trajectory toward USD 7.19 billion by 2035 at 23.2% CAGR reflects an extraordinary growth inflection driven by FDA regulatory mandate, infection control imperatives, and cost parity evidence enabling conversion across all major flexible endoscope categories. Ambu aScope Duodeno ERCP adoption, Olympus Vaya disposable bronchoscope launch, and Vedkang Medical ureteroscope international expansion confirm the disposable endoscopes market will sustain one of the most exceptional growth trajectories in the entire medical devices sector through 2035.

About Constancy Researchers Private Limited

Constancy Researchers is a global market intelligence and strategic advisory firm helping organizations navigate complex markets and make high-impact decisions with confidence. In an environment defined by rapid technological change, shifting demand patterns, and evolving competitive dynamics, we provide clarity where it matters most—at the point of decision-making. By combining deep industry understanding, rigorous analytics, and structured thinking, we enable leadership teams to identify opportunities, mitigate risks, and build strategies that drive sustainable growth.

Speak with an Analyst

    Download TOC